共 50 条
- [32] Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy Advances in Therapy, 2020, 37 : 2572 - 2573
- [33] Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment (May, 10.1007/s12325-022-02166-6, 2022) ADVANCES IN THERAPY, 2022, 39 (08) : 3522 - 3523
- [37] Preservative-free tafluprost 0.0015%/timolol 0.5% fixed dose combination: a 6-month double-masked, randomized multicenter P-III comparison to concomitant use of the individual preservative-free components in patients with glaucoma or ocular hypertension INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
- [39] THE COST-EFFECTIVENESS OF BIMATOPROST 0.03%/TIMOLOL 0.05% PRESERVATIVE-FREE FIXED COMBINATION COMPARED WITH DORZOLAMIDE/TIMOLOL PRESERVATIVE-FREE FIXED COMBINATION AND 2-BOTTLE UNFIXED COMBINATIONS FOR THE TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA IN THE UNITED KINGDOM VALUE IN HEALTH, 2013, 16 (07) : A506 - A507
- [40] 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy (vol 34, pg 221, 2020) ADVANCES IN THERAPY, 2020, 37 (05) : 2572 - 2573